To join a tinnitus clinical trial, search ClinicalTrials.gov for tinnitus studies marked recruiting, contact the research team listed on the record, and attend a screening appointment; your own doctor or a nearby university hospital may know of studies too.
What is being studied, and what has already reported, is covered in where tinnitus research is headed. This page is the practical part: finding a study, getting in touch, and deciding whether it is right for you.
Where to look
ClinicalTrials.gov, run by the US National Library of Medicine, is the main registry. It includes studies in all 50 US states and over 200 countries. On 26 September 2026, a search for tinnitus returned 43 studies recruiting participants, 42 of them clinical trials. Another 28 were registered but not yet recruiting.
To search it the way the registry itself recommends: enter tinnitus as the condition, add your location and a radius, use the eligibility filters for age and sex, and set the study status to recruiting (or "recruiting and not yet recruiting" to see what is coming). Then open the records that interest you and read the participation criteria.
It is worth knowing what a listing does and does not mean. The US government does not review or approve the safety and science of every study on ClinicalTrials.gov; NIH and other agencies approve only the studies they fund. The National Library of Medicine does a limited review of what sponsors submit, and the sponsor or investigator is responsible for the study's safety, science and accuracy. Not every study anywhere in the world is listed, either.
Beyond the registry, the American Tinnitus Association suggests three more routes: participant-matching platforms such as ResearchMatch, contacting the research departments of research centres, universities and hospitals near you, and — perhaps the most straightforward — raising it with your own healthcare provider, who may already know of relevant trials or be able to refer you.
Getting in touch and getting screened
You can't sign up for a study through ClinicalTrials.gov itself — the site is a registry, not an enrolment platform. Look in the record's Contacts and Locations section for a location that works for you and a central or local contact, then call or email them. Once a study has finished recruiting, the contact details disappear from the record.
If an initial conversation suggests you might qualify, researchers typically invite you to a formal screening appointment to confirm you meet all of the study's requirements before you are enrolled and assigned to a group. Study records are not always up to date: if you don't hear back, it is worth trying again, and the study may simply have finished without the record being updated.
What to expect
Tinnitus studies vary widely, from online surveys to device and medication trials with repeated in-person visits, so the time and travel involved vary with them.
Placebo and sham arms. Of the 42 recruiting tinnitus clinical trials on the registry in late September 2026, 14 had a placebo or sham comparison arm. A comparison group is how a trial shows whether a treatment does anything beyond the improvement people see from being assessed and looked after — what happens if you do nothing puts a number on that. A placebo arm is not nothing, either: a 2024 meta-analysis of 23 randomised drug trials found that people given a placebo improved by 5.6 points on the Tinnitus Handicap Inventory on average, though by less than people given active treatment. If your main goal is access to a new treatment rather than contributing to research, check the record's arms before you enrol.
Payment and costs. ClinicalTrials.gov says some studies pay participants, by amounts that vary; many pay for the intervention being tested and for research-related tests and visits; and some cover research-related travel and lodging, such as parking. None of that should be assumed — ask.
Risk. Every study carries some level of risk. You may have side effects, you may be given the standard treatment or no treatment rather than the one being tested, and the intervention may turn out not to work.
Questions worth asking before you join
Before you decide, you go through informed consent: a process, and a document, that should tell you what will happen during the study, who can join, how much of your time it will take, any payments and any costs you may have to pay, and the known benefits and risks. Research staff are there to answer questions about it, and it is reasonable to talk it over with your doctor and with family or friends.
Useful questions to bring:
- Could I be in a placebo, sham or waiting-list group? And if so, will I be offered the treatment afterwards?
- How many visits, over how long, and where? Is any of it remote?
- What will I be paid, and what will I have to pay? Travel, parking, time off work.
- What happens to my tinnitus care during the study? Can I keep using hearing aids, sound therapy or CBT?
- Who is funding it? A trial run by the company that makes the product is legitimate, and worth knowing about.
The legitimate route runs through a registry entry and a named research team. A "trial" that asks you to pay for the treatment, or that reaches you through an advert with no registry number, is worth checking carefully before you go further. When results come out, the patterns that make a weak tinnitus result look strong is a guide to reading them.